Back
Disc Medicine Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
66
IRON
Disc Medicine
Last Price:
47.92
Seasonality Move:
-2.7%
Sell
25
ALNY
Alnylam Pharmaceuticals
Last Price:
271.68
Seasonality Move:
5.61%
Buy
66
Disc Medicine (IRON)
is a Buy
Is Disc Medicine a Buy, Sell or Hold?
- The current Disc Medicine [IRON] share price is $47.68. The Score for IRON is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- IRON is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $270.37. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $47.68
The current trend is moderately bearish and IRON is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $270.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
IRON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 47.7 | Sell |
| Chaikin Money Flow: | -11626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.24 - 50.36) | Sell |
| Bollinger Bands (100): | (34.22 - 48.68) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 57.05 | Buy |
| Chaikin Money Flow: | 372073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.23 - 277.27) | Buy |
| Bollinger Bands (100): | (160.25 - 266.23) | Buy |
IRON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.24 | Sell |
| 20-day SMA: | 49.38 | Sell |
| 50-day SMA: | 46.89 | Buy |
| 200-day SMA: | 49.46 | Sell |
| 8-day EMA: | 48.71 | Sell |
| 20-day EMA: | 48.58 | Sell |
| 50-day EMA: | 46.74 | Buy |
| 200-day EMA: | 45.87 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 258.32 | Buy |
| 20-day SMA: | 266.87 | Buy |
| 50-day SMA: | 258.66 | Buy |
| 200-day SMA: | 190.06 | Buy |
| 8-day EMA: | 262.74 | Buy |
| 20-day EMA: | 262.76 | Buy |
| 50-day EMA: | 250.83 | Buy |
| 200-day EMA: | 206 | Buy |
Disc Medicine Earnings Growth & IRON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.28 per share, and a decrease next year of $0.51 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Disc Medicine Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||